Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type 1 diabetes

Diabetes Care

Volumn 30, Issue 3, 2007, Pages 649-654

  Ceriello, Antonio ^a,d   Kumar, Sudhesh ^a   Piconi, Ludovica ^b   Esposito, Katerine ^c   Giugliano, Dario ^c  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b Morpurgo Hofman Research Laboratory on Aging   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ASCORBIC ACID; NEUTRAL INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; ENDOTHELIAL DYSFUNCTION; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MONOTHERAPY; OXIDATIVE STRESS;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN; LIPIDS; LIPOPROTEINS; MALE; OXIDATIVE STRESS; REFERENCE VALUES; VASODILATION;

EID: 33847612960     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2048     Document Type: Article

References (39)

1. Dorman JS, Laporte RE, Kuller LH, Cruickshanks KJ, Orchard TJ, Wagener DK, Becker DJ, Cavendar DE, Drash AL: The Pittsburgh Insulin-Dependent Diabetes Mellitus (IDDM) Morbidity and Mortality Study: mortality results. Diabetes 33:271-276, 1984
2. Schwab KO, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, Kordonouri O, Beyer P, Holl RW, DPV Initiative of the German Working Group for Pediatric Diabetology: DPV Initiative of the German Working Group for Pediatric Diabetology. Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 29:218 -2125, 2006
3. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM Ochard TJ, Raskin P, Zinman B, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653, 2005
4. Esper RJ, Nordaby RA, Vilarino JO, Paragano A, Cacharron JL, Machado RA: Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol 5:4, 2006
5. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D'Onofrio F: Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95:1783-1790, 1997
6. Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E: Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 106:1211-1218, 2002
7. Sorensen VR, Mathiesen ER, Clausen P, Flyvbjerg A, Feldt-Rasmussen B: Impaired vascular function during short-term poor glycaemic control in type 1 diabetic patients. Diabet Med 22:871-876, 2005
8. Huvers FC, De Leeuw PW, Houben AJ, De Haan CH, Hamulyak K, Schouten H, Wolffenbuttel BH, Schaper NC: Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes 48:1300-1307, 1999
9. Dogra G, Rich L, Stanton K, Watts GF: Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia 44:593-601, 2001
10. Ceriello A: New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 25:1589-1596, 2003
11. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
12. Mullan BA, Ennis CN, Fee HJ, Young IS, McCance DR: Pretreatment with intravenous ascorbic acid preserves endothelial function during acute hyperglycaemia (R1). Clin Exp Pharmacol Physiol 32:340-345, 2005
13. Warnick GR, Nguyen T, Albers AA: Comparison of improved precipitation methods for quantification of HDL cholesterol. Clin Chem 31:217-222, 1995
14. Graham JM, Higgins JA, Gillott T, Taylor T, Wilkinson J, Ford T, Billington D: A novel method for the rapid separation of lipoproteins using self-generating gradients of iodixanol. Atherosclerosis 124:124-135, 1996
15. ter Steege JCA, Koster-Kamphuis L, van Straaten E, Forget PP, Burrman WA: Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic Biol Med 25:953-963, 1998
16. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Toboga C: Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 44:834-838, 2001
17. Sokolovsky M, Riordan JF, Valle BL: Tetranitromethane: a reagent for the nitration of tyrosil residues in proteins. Biochemistry 5:3582-3589, 1966
18. Corretti MC, Plotnick GD, Vogel RA: Technical aspects of evaluating brachial artery endothelium-dependent vasodilation using high frequency ultrasound. Am J Physiol 268:H1397-H1404, 1995
19. Ramsey M, Goodfellow J, Jones C, Luddington L, Lewis MJ, Henderson AH: Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 92:3212-3219, 1995
20. Ceriello A, Assaloni R, Da Ros R, Maier A, Piconi L, Quagliaro L, Esposito K, Giugliano D: Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 111:2518-2524, 2005
21. Timimi FK, Ting HH, Haley EA, Roddy MA, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 31:552-557, 1998
22. Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulieiit A, Van Etten E, Herijgers P, Mathieu C, Van den Berghe G: Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 55:1096-1105, 2006
23. Ceriello A, Ihnat M, Ross K, Sismey A, Green DW, Kaltreider RC, Piconi L, Leeper MR, Kamat CD: Evidence for a cellular "memory" of hyperglycemic stress (Abstract). Diabetes 54 (Suppl. 1):A54, 2005
24. Nishikawa T, Edelstein D, Du X-L, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
25. Spitaler MM, Graier WF: Vascular targets of redox signalling in diabetes mellitus. Diabetologia 45:476-494, 2002
26. Benz D, Cadet P, Mantione K, Zhu W, Stefano GB: Tonal nitric oxide and health - a free radical and scavenger of free radicals. Med Sci Monit 8:RA1-RA4, 2002
27. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437, 1996
28. Cosentino F, Hishikawa K, Katusic ZS, Lüscher TF: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25-28, 1997
29. Ceriello A, Quagliaro L, D'Amico M, De Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D: Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51:1076-1082, 2002
30. Llorens S, Nava E: Cardiovascular diseases and the nitric oxide pathway. Curr Vasc Pharmacol 1:335-346, 2003
31. Ischiropoulos H: Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 356:1-11, 1998
32. Prutz WA, Monig H, Butler J, Land EJ: Reactions of nitrogen dioxide in aqueous model systems: oxidation of tyrosine units in peptides and proteins. Arch Biochem Biophys 243:125-134, 1985
33. Pacher P, Szabo C: Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opin Pharmacol 6:136-141, 2006
34. Pacher P, Szabo C: Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complication: endothelial dysfunction, as a common underlying theme. Antioxid Redox Signal 7:1568-1580, 2005
35. Beisswenger PJ, Howell SK, Nelson RG, Mauer M, Szwergold BS: α-Oxoaldehyde metabolism and diabetic complications. Biochem Soc Trans 31:1358-1363, 2003
36. Rosca MG, Mustata TG, Kinter MT, Ozdemir AM, Kern TS, Szweda LI, Brownlee M, Monnier VM, Weiss MF: Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol 289:F420-F430, 2005
37. Shishehbor MH, Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, Gokce N, Keaney JF Jr, Penn MS, Sprecher DL: Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289:1675-1680, 2003
38. Goldfine AB, Beckman JA, Betensky RA, Devlin H, Hurley S, Varo N, Schonbeck U, Patti ME, Creager MA: Family history of diabetes is a major determinant of endothelial function. J Am Coll Cardiol 47:2456-2461, 2006
39. Rodriguez CJ, Miyake Y, Grahame-Clarke C, Di Tullio MR, Sciacca RR, Boden-Albala B, Sacco RL, Homma S: Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol 96:1273-1277, 2005